State Board of Administration of Florida Retirement System lessened its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 2.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 340,291 shares of the medical instruments supplier’s stock after selling 9,170 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in DENTSPLY SIRONA were worth $16,875,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the stock. Gamco Investors INC. ET AL lifted its stake in shares of DENTSPLY SIRONA by 1.7% in the 1st quarter. Gamco Investors INC. ET AL now owns 116,620 shares of the medical instruments supplier’s stock valued at $5,783,000 after purchasing an additional 1,990 shares in the last quarter. Gabelli Funds LLC lifted its stake in shares of DENTSPLY SIRONA by 102.6% in the 1st quarter. Gabelli Funds LLC now owns 79,000 shares of the medical instruments supplier’s stock valued at $3,918,000 after purchasing an additional 40,000 shares in the last quarter. Hartz Capital Inc. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $1,063,000. Veritas Asset Management LLP lifted its stake in shares of DENTSPLY SIRONA by 0.6% in the 1st quarter. Veritas Asset Management LLP now owns 13,549,320 shares of the medical instruments supplier’s stock valued at $671,911,000 after purchasing an additional 76,545 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. lifted its stake in shares of DENTSPLY SIRONA by 62.7% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 225,732 shares of the medical instruments supplier’s stock valued at $11,195,000 after purchasing an additional 86,970 shares in the last quarter. Hedge funds and other institutional investors own 95.83% of the company’s stock.
In other news, SVP Maureen J. Macinnis sold 54,402 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $55.00, for a total value of $2,992,110.00. Following the completion of the sale, the senior vice president now directly owns 50,962 shares in the company, valued at approximately $2,802,910. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Eric Brandt sold 9,160 shares of the business’s stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $53.45, for a total value of $489,602.00. Following the completion of the sale, the director now owns 26,003 shares of the company’s stock, valued at $1,389,860.35. The disclosure for this sale can be found here. Insiders have sold a total of 101,022 shares of company stock worth $5,535,985 over the last 90 days. 0.62% of the stock is owned by company insiders.
XRAY stock opened at $54.87 on Thursday. The company has a current ratio of 2.06, a quick ratio of 1.35 and a debt-to-equity ratio of 0.33. DENTSPLY SIRONA Inc has a 52-week low of $33.93 and a 52-week high of $55.88. The company has a market cap of $12.84 billion, a price-to-earnings ratio of 27.30, a price-to-earnings-growth ratio of 2.04 and a beta of 1.11.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a positive return on equity of 8.99% and a negative net margin of 26.48%. The company had revenue of $946.20 million for the quarter, compared to the consensus estimate of $925.13 million. During the same period in the previous year, the business earned $0.45 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 1.0% compared to the same quarter last year. On average, equities analysts forecast that DENTSPLY SIRONA Inc will post 2.34 EPS for the current fiscal year.
Several equities analysts have recently weighed in on the company. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $61.00 price objective on the stock in a research note on Saturday, May 11th. BidaskClub raised DENTSPLY SIRONA from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 price objective on the stock in a research note on Monday, May 6th. ValuEngine raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Guggenheim assumed coverage on DENTSPLY SIRONA in a research note on Wednesday, April 17th. They issued a “neutral” rating and a $54.00 price objective on the stock. Eight research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $53.65.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://transcriptdaily.com/2019/05/16/state-board-of-administration-of-florida-retirement-system-sells-9170-shares-of-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Story: Calculate Your Return on Investment (ROI)
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.